EcoCeres Will Target $1 Billion Hong Kong IPO in 2026
The renewable fuel producer plans a public listing as it scales production capacity to 770,000 metric tons per year.
Live Poll
Is now a good time to invest in sustainable aviation fuel companies?
World Biotech
Recent news
September 24, 2026
Researchers Developed PeakATail for RNA SequencingThe new tool maps polyadenylation sites at single-cell resolution to refine RNA analysis across human tissues.
September 24, 2026
Researchers Automated In Silico Cell Perturbation ScreensThe ISP Platform uses Geneformer models to identify genetic sequences required for stem cell state transitions.
September 24, 2026
Researchers Built New Protein Fitness Prediction ModelThe Cerebra-Epistasis framework predicts multi-mutant fitness outcomes by integrating structure awareness and sequence data.
September 24, 2026
Voyager and Exobiosphere Will Expand ISS ResearchThe two firms will add two microgravity biotechnology campaigns starting in June 2027.
September 24, 2026
Researchers Released Privacy-Preserving Gene Analysis ToolThe new FedEdgeR platform allows decentralized RNA-seq analysis without compromising sensitive patient data.
September 24, 2026
JNC Showcased Chromatography Products for Viral VectorsThe company presented research-stage media designed to purify large biological particles more efficiently.
September 24, 2026
Researchers Reduced Protein Database Index MemoryA new lossless compression algorithm lowers memory requirements by over 33 percent for large-scale protein sequence classification.
September 24, 2026
Researchers Released SIMworks Microscopy Software SuiteThe new integrated platform standardizes data processing and quantitative analysis for structured illumination microscopy.
September 24, 2026
Henlius Biotech Signed $440 Million Licensing DealShanghai-based Henlius partnered with Amberstone Biosciences to develop T-cell engagers for cancer treatment.
September 24, 2026
Daiichi Sankyo Expanded ADC Discovery PartnershipThe pharmaceutical firm will utilize Turbine’s vLab platform to simulate drug responses and optimize its growing pipeline of antibody-drug conjugates.